Insider: Eckelman Brendan P. Chief Scientific Officer - Inhibrx, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,735,553 | 1,735,553 | |
| Value | $ | $56,717,872.04 | $56,717,872.04 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/28/2024 | DDS | 300,000 | Indirect | COM | $34.30 | $10,290,000.00 | 1,735,553 |
| 03/01/2023 | DDS | 39,600 | Indirect | COM | $24.20 | $958,347.72 | 2,035,953 |
| 03/01/2023 | DDS | 400 | Indirect | COM | $24.71 | $9,883.00 | 2,035,553 |
| 02/02/2023 | DDS | 10,120 | Indirect | COM | $25.40 | $257,093.54 | 2,076,683 |
| 02/02/2023 | DDS | 1,130 | Indirect | COM | $25.89 | $29,261.01 | 2,075,553 |
| 02/01/2023 | DDS | 13,449 | Indirect | COM | $24.29 | $326,709.83 | 2,102,104 |
| 02/01/2023 | DDS | 14,608 | Indirect | COM | $25.08 | $366,365.72 | 2,087,496 |
| 02/01/2023 | DDS | 693 | Indirect | COM | $25.66 | $17,780.09 | 2,086,803 |
| 01/04/2023 | DDS | 4,102 | Indirect | COM | $23.11 | $94,785.73 | 2,118,556 |
| 01/04/2023 | DDS | 3,003 | Indirect | COM | $23.99 | $72,042.87 | 2,115,553 |
| 01/03/2023 | DDS | 2,084 | Indirect | COM | $25.09 | $52,293.19 | 2,122,658 |
| 01/03/2023 | DDS | 22,213 | Indirect | COM | $23.41 | $520,050.76 | 2,133,340 |
| 01/03/2023 | DDS | 8,598 | Indirect | COM | $24.36 | $209,425.79 | 2,124,742 |
| 12/06/2022 | DDS | 20,927 | Indirect | COM | $26.83 | $561,571.86 | 2,174,626 |
| 12/06/2022 | DDS | 1,392 | Indirect | COM | $28.46 | $39,617.43 | 2,155,553 |
| 12/06/2022 | DDS | 17,681 | Indirect | COM | $27.57 | $487,493.46 | 2,156,945 |
| 11/01/2022 | DDS | 27,651 | Indirect | COM | $33.34 | $921,746.09 | 2,207,902 |
| 11/01/2022 | DDS | 12,349 | Indirect | COM | $33.90 | $418,640.98 | 2,195,553 |
| 10/04/2022 | DDS | 6,207 | Indirect | COM | $26.06 | $161,763.11 | 2,267,898 |
| 10/04/2022 | DDS | 1,448 | Indirect | COM | $24.67 | $35,720.42 | 2,274,105 |
| 10/04/2022 | DDS | 100 | Indirect | COM | $30.52 | $3,052.00 | 2,235,553 |
| 10/04/2022 | DDS | 11,136 | Indirect | COM | $26.78 | $298,181.99 | 2,256,762 |
| 10/04/2022 | DDS | 4,262 | Indirect | COM | $27.76 | $118,298.63 | 2,252,500 |
| 10/04/2022 | DDS | 10,893 | Indirect | COM | $29.68 | $323,302.06 | 2,235,653 |
| 10/04/2022 | DDS | 5,954 | Indirect | COM | $28.97 | $172,495.12 | 2,246,546 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research